| Topoisomerase I inhibitor |
| Topotecan |
| Topotecan (BAN) |
| Topotecan hydrochloride (USAN); Nogitecan hydrochloride (JAN) <JP/US> |
| Irinotecan |
| Irinotecan (INN) |
| Irinotecan hydrochloride (USP); Irinotecan hydrochloride hydrate (JP18) <JP/US> |
| Irinotecan sucrosofate (USAN) |
| Etirinotecan pegol |
| Etirinotecan pegol (USAN/INN) |
| Etirinotecan pegol tetrahydrochloride (USAN) |
| Etirinotecan pegol tetratriflutate (USAN) |
| Belotecan hydrochloride (USAN) |
| Exatecan mesylate (USAN); Exatecan mesilate hydrate (JAN) |
| Edotecarin (USAN/INN) |
| Rubitecan (USAN/INN) |
| Lurtotecan dihydrochloride (USAN) |
| Pegamotecan (USAN) |
| Cositecan (USAN) |
| Tenifatecan (USAN/INN) |
| Firtecan pegol (USAN/INN) |
| Topoisomerase II inhibitor |
| Doxorubicin |
| Doxorubicin (USAN/INN) |
| Doxorubicin hydrochloride (JP18/USP) <JP/US> |
| Daunorubicin |
| Daunorubicin (INN) |
| Daunorubicin hydrochloride (JP18/USP) <JP/US> |
| Daunorubicin citrate |
| Epirubicin |
| Epirubicin (INN) |
| Epirubicin hydrochloride (JP18/USP) <JP/US> |
| Idarubicin |
| Idarubicin (INN) |
| Idarubicin hydrochloride (JP18/USP) <JP/US> |
| Mitoxantrone |
| Mitoxantrone (INN) |
| Mitoxantrone hydrochloride (JAN/USP) <JP/US> |
| Pirarubicin |
| Pirarubicin (JP18/INN) |
| Pirarubicin hydrochloride <JP> |
| Amrubicin |
| Amrubicin (USAN/INN) |
| Amrubicin hydrochloride (JAN/USAN) <JP> |
| Pixantrone |
| Pixantrone (USAN/INN) |
| Pixantrone dimaleate (USAN) |
| Etoposide |
| Etoposide (JP18/USP/INN) <JP/US> |
| Etoposide phosphate (USAN) <US> |
| Teniposide (USP/INN) |
| Amsacrine (USAN/INN) |
| Vosaroxin (USAN) |
| Sobuzoxane (JAN) <JP> |
| Amonafide |
| Amonafide (USAN) |
| Amonafide l-malate (USAN) |
| Crisnatol mesylate (USAN) |
| Idronoxil (USAN/INN) |
| Ledoxantrone trihydrochloride (USAN) |
| Berubicin hydrochloride (USAN) |
| Quarfloxin (USAN) |
| Naxtarubicin (USAN) |
| Aclarubicin |
| Aclarubicin (USAN/INN) |
| Aclarubicin hydrochloride (JP18) <JP> |
| Elsamitrucin (USAN/INN) |
